Clinical Trials Browser

Interventional × Papillomavirus Infections × 90 days × Clear all

NCT07545746 2026-04-22

Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT06498661 2026-04-21

SHIP-A-S01

Phase NA Active not recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07521163 2026-04-15

HBM-HPV

Phase NA Not yet recruiting

Uterine Cervical Neoplasms, Health Education, Papillomavirus Infections

NCT05797246 2026-04-14

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Phase 2 Active not recruiting

DNA Virus Infections, Infections, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Pathologic Processes, Recurrence, Respiratory Tract Diseases, Respiratory Tract Infections, Tumor Virus Infections, Virus Diseases, Neoplasms, Squamous Cell, Disease Attributes, Papillomavirus Infections

NCT03036930 2026-04-13

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

Phase 2 Active not recruiting

51 enrolled 10 charts

Papillomavirus Infections

NCT07200414 2026-04-13

SHARP

Phase NA Completed

12,654 enrolled

Infections, Papillomavirus Infections

NCT07217145 2026-04-07

PREVENT HPV -Related Cancers Trial

Phase 3 Active not recruiting

Behavior, Communication, Neoplasms, Patient Acceptance of Health Care, Papillomavirus Infections

NCT03903562 2026-04-06

V503-024

Phase 3 Completed

1,990 enrolled 42 charts

Papillomavirus Infections

NCT01898494 2026-04-01

Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

Phase 2 Active not recruiting

519 enrolled 16 charts

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT06784960 2026-03-30

Communication Strategies to Increase HPV Vaccination Intention

Phase NA Completed

Vaccination Hesitancy, Communication, Papillomavirus Infections

NCT06210854 2026-03-24

Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+

Phase 2 Not yet recruiting

Papillomavirus Infections

NCT04226313 2026-03-23

KOPRETINA

Phase NA Recruiting

15,000 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06738355 2026-03-20

PREVENT Pilot HPV - Related Cancers Trial

Phase NA Completed

Vaccination Refusal, Behavior, Communication, Neoplasms, Patient Acceptance of Health Care, Papillomavirus Infections

NCT05935644 2026-03-19

ORCHID-Miami

Phase NA Enrolling by invitation

Acquired Immunodeficiency Syndrome, Depression, Papillomavirus Infections

NCT06256718 2026-03-17

Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care

Phase NA Active not recruiting

Papillomavirus Infections

NCT07461818 2026-03-11

POC

Phase NA Recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Phase 1/2 Completed

224 enrolled 15 charts

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

NCT07209189 2026-03-09

(NeoScorch HN)

Phase 2 Recruiting

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT07453459 2026-03-06

Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening

Phase NA Not yet recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07447245 2026-03-03

(HPV)

Phase NA Recruiting

Papillomavirus Infections

NCT07428330 2026-02-27

CASCADE3001A

Phase NA Recruiting

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT07225530 2026-02-25

(iSTAR)

Phase NA Recruiting

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT05334706 2026-02-23

RIFT-HPV

Phase 4 Recruiting

Uterine Cervical Neoplasms, Infections, Papillomavirus Infections, Squamous Intraepithelial Lesions of the Cervix

NCT07209917 2026-02-23

ASHA-Health II

Phase NA Recruiting

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms, Infections, Papillomavirus Infections

NCT05883111 2026-02-19

Self-TI

Phase NA Active not recruiting

Papillomavirus Infections

NCT07420556 2026-02-19

Effect of Different HPV Education Methods on Vaccination Intention in Young Women

Phase NA Recruiting

Health Education, Infections, Papillomavirus Infections

NCT06491446 2026-02-18

Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

Phase 1/2 Active not recruiting

Sexually Transmitted Diseases, Papillomavirus Infections

NCT07418034 2026-02-18

SAVED

Phase 2 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT07281430 2026-02-17

LMI-001-A-S04

Phase NA Recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07033091 2026-02-13

Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening

Phase NA Recruiting

20,000 enrolled

Oropharyngeal Neoplasms, Papillomavirus Infections

NCT07303751 2026-02-11

RIFT-SSA

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms, Infections, Papillomavirus Infections, Squamous Intraepithelial Lesions of the Cervix

NCT01932697 2026-02-10

Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer

Phase 2 Completed

81 enrolled 18 charts

Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections

NCT05119855 2026-02-05

Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)

Phase 3 Completed

165 enrolled 13 charts

COVID-19, Papillomavirus Infections

NCT07281599 2026-02-02

EQUIP

Phase NA Recruiting

Genital Diseases, Uterine Cervical Neoplasms, Sexually Transmitted Diseases, Sexually Transmitted Diseases, Viral, Papillomavirus Infections

NCT04206813 2026-01-27

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

Phase 4 Active not recruiting

Papillomavirus Infections